Published in J Health Care Poor Underserved on November 01, 2006
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med (2009) 5.48
Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood (2009) 3.18
Clinical utility of D-dimer in patients with suspected pulmonary embolism and nondiagnostic lung scans or negative CT findings. Chest (2004) 2.30
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood (2008) 2.17
The potential protective effects of youth assets from adolescent sexual risk behaviors. J Adolesc Health (2004) 1.95
Parental communication and youth sexual behaviour. J Adolesc (2006) 1.87
Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica (2007) 1.87
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion (2004) 1.84
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol (2010) 1.83
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood (2010) 1.76
Practice facilitators: a review of the literature. Fam Med (2005) 1.68
Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol (2009) 1.56
Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf (2009) 1.52
Youth-parent communication and youth sexual behavior: implications for physicians. Fam Med (2006) 1.50
Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood (2014) 1.47
Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist (2007) 1.45
The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract (2004) 1.34
Relationships among youth assets and neighborhood and community resources. Health Educ Behav (2005) 1.28
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion (2012) 1.27
Impact of a Wellness Portal on the delivery of patient-centered preventive care. J Am Board Fam Med (2012) 1.20
Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion (2007) 1.19
The potential protective effect of youth assets on adolescent alcohol and drug use. Am J Public Health (2004) 1.16
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer (2013) 1.16
Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion (2006) 1.14
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood (2013) 1.13
Reliability and validity of the youth asset survey (YAS). J Adolesc Health (2002) 1.12
Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol (2011) 1.10
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS. Semin Hematol (2004) 1.09
The effectiveness of magnet therapy for treatment of wrist pain attributed to carpal tunnel syndrome. J Fam Pract (2002) 1.09
Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion (2009) 1.09
Youth assets and sexual risk behavior: the importance of assets for youth residing in one-parent households. Perspect Sex Reprod Health (2005) 1.00
Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus. South Med J (2007) 1.00
Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood (2002) 1.00
Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica (2011) 0.99
An adolescent age group approach to examining youth risk behaviors. Am J Health Promot (2002) 0.96
Adolescent tobacco use: the protective effects of developmental assets. Am J Health Promot (2002) 0.96
Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. Am J Hematol (2003) 0.93
Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher (2006) 0.93
Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol (2011) 0.93
Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol (2010) 0.92
The association between multiple youth assets and sexual behavior. Am J Health Promot (2004) 0.92
Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion (2009) 0.92
Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis (2009) 0.91
Quality improvement as a tool for translating evidence based interventions into practice: what the youth violence prevention community can learn from healthcare. Am J Community Psychol (2011) 0.90
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion (2011) 0.90
Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion (2003) 0.90
Protective assets for non-use of alcohol, tobacco and other drugs among urban American Indian youth in Oklahoma. Matern Child Health J (2008) 0.90
Drug-induced thrombocytopenia in children. Pediatr Blood Cancer (2013) 0.90
Management of prescription refills in primary care: an Oklahoma Physicians Resource/Research Network (OKPRN) study. J Am Board Fam Med (2006) 0.89
Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol (2012) 0.88
Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med (2012) 0.88
Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood (2009) 0.88
Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf (2007) 0.88
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection. Eur J Haematol (2008) 0.87
First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion (2013) 0.86
Socioeconomic factors and health risk behaviors among adolescents. Am J Health Behav (2010) 0.86
Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual (2013) 0.86
Youth assets and sexual risk behavior: differences between male and female adolescents. Health Educ Behav (2009) 0.86
Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion (2009) 0.86
Clinical decision-making in blood pressure management of patients with diabetes mellitus: an Oklahoma Physicians Resource/Research Network (OKPRN) Study. J Am Board Fam Med (2006) 0.86
Youth assets, aggression, and delinquency within the context of family structure. Am J Health Behav (2005) 0.85
School-related assets and youth risk behaviors: alcohol consumption and sexual activity. J Sch Health (2012) 0.85
Does patient assessment of the quality of the primary care they receive predict subsequent outcomes?: An Oklahoma Physicians Resource/Research Network (OKPRN) study. J Am Board Fam Med (2012) 0.85
A youth development approach to profiling sexual abstinence. Am J Health Behav (2003) 0.85
Methodological considerations in a community-based longitudinal study. Am J Health Behav (2008) 0.85
Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry. J Clin Apher (2008) 0.85
Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol (2008) 0.84
Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion (2008) 0.84
A longitudinal study of youth assets, neighborhood conditions, and youth sexual behaviors. J Adolesc Health (2013) 0.83
Reliability and validity of the youth asset survey: an update. Am J Health Promot (2010) 0.82